Chemotherapy, Cancer, Regional Perfusion
"Chemotherapy, Cancer, Regional Perfusion" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Neoplasm drug therapy involving an extracorporeal circuit with temporary exclusion of the tumor-bearing area from the general circulation during which high concentrations of the drug are perfused to the isolated part.
| Descriptor ID |
D010478
|
| MeSH Number(s) |
E02.319.267.200 E04.292.425
|
| Concept/Terms |
Chemotherapy, Cancer, Regional Perfusion- Chemotherapy, Cancer, Regional Perfusion
- Regional Perfusion Antineoplastic Chemotherapy
- Isolation Perfusion Cancer Chemotherapy
- Cancer Chemotherapy, Regional Perfusion
- Perfusion Cancer Chemotherapy, Regional
- Regional Perfusion Cancer Chemotherapy
|
Below are MeSH descriptors whose meaning is more general than "Chemotherapy, Cancer, Regional Perfusion".
Below are MeSH descriptors whose meaning is more specific than "Chemotherapy, Cancer, Regional Perfusion".
This graph shows the total number of publications written about "Chemotherapy, Cancer, Regional Perfusion" by people in this website by year, and whether "Chemotherapy, Cancer, Regional Perfusion" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 1997 | 2 | 1 | 3 |
| 1998 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2000 | 1 | 1 | 2 |
| 2003 | 1 | 1 | 2 |
| 2004 | 2 | 0 | 2 |
| 2005 | 1 | 1 | 2 |
| 2006 | 1 | 0 | 1 |
| 2007 | 2 | 1 | 3 |
| 2008 | 3 | 1 | 4 |
| 2009 | 2 | 3 | 5 |
| 2010 | 4 | 1 | 5 |
| 2011 | 4 | 1 | 5 |
| 2012 | 5 | 1 | 6 |
| 2013 | 4 | 3 | 7 |
| 2014 | 1 | 1 | 2 |
| 2015 | 4 | 1 | 5 |
| 2016 | 1 | 0 | 1 |
| 2017 | 2 | 2 | 4 |
| 2018 | 1 | 0 | 1 |
| 2019 | 3 | 1 | 4 |
| 2020 | 2 | 7 | 9 |
| 2021 | 0 | 2 | 2 |
| 2022 | 0 | 2 | 2 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Chemotherapy, Cancer, Regional Perfusion" by people in Profiles.
-
Preoperative CA 19-9 Predicts Disease Progression in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Analysis from the US HIPEC Collaborative. Ann Surg Oncol. 2024 May; 31(5):3314-3324.
-
Influence of insurance status on the postoperative outcomes of cytoreductive surgery and HIPEC. J Surg Oncol. 2023 Mar; 127(4):706-715.
-
Do Lymph Node Metastases Matter in Appendiceal Cancer with Peritoneal Carcinomatosis? A US HIPEC Collaborative Study. J Gastrointest Surg. 2022 12; 26(12):2569-2578.
-
Risk of Intraoperative Hyperthermia and Outcomes in Adults Undergoing Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC). Ann Surg Oncol. 2022 Mar; 29(3):2089-2099.
-
Impact of Perioperative Blood Transfusions on Outcomes After Hyperthermic Intraperitoneal Chemotherapy: A Propensity-Matched Analysis. Ann Surg Oncol. 2021 Aug; 28(8):4499-4507.
-
Neuroendocrine Tumors: Imaging of Treatment and Follow-up. Radiol Clin North Am. 2020 Nov; 58(6):1161-1171.
-
CRS/HIPEC with Major Organ Resection in Peritoneal Mesothelioma Does not Impact Major Complications or Overall Survival: A Retrospective Cohort Study of the US HIPEC Collaborative. Ann Surg Oncol. 2020 Dec; 27(13):4996-5004.
-
A novel preoperative risk score to optimize patient selection for performing concomitant liver resection with cytoreductive surgery/HIPEC. J Surg Oncol. 2021 Jan; 123(1):187-195.
-
Laparoscopic HIPEC for Low-Volume Peritoneal Metastasis in Gastric and Gastroesophageal Adenocarcinoma. Ann Surg Oncol. 2020 Dec; 27(13):5047-5056.
-
Predictors of Non-home Discharge after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. J Surg Res. 2020 11; 255:475-485.